Skip to main content

Bill C-239

If you have any questions or comments regarding the accessibility of this publication, please contact us at



This enactment establishes criteria for regulations to be made under the Food and Drugs Act respecting the process for applications for the approval of new drugs, the review of such applications and the making of decisions. It mandates the due consideration of processes established outside Canada and in particular requires the process to carried out as least as quickly as the equivalent process in the European Community.

It also requires sufficient staffing, open dealings with applicants respecting the time to be taken and the professional independence of the scientists who review applications.

It requires the Minister to report annually to Parliament on the review process.